Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8205)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 15, 2019 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhu YL, Sun YK, Xue XM, Yue JY, Yang L, Xue LY. Unnecessity of lymph node regression evaluation for predicting gastric adenocarcinoma outcome after neoadjuvant chemotherapy. World J Gastrointest Oncol 2019; 11(1): 48-58 [PMID: 30984350 DOI: 10.4251/wjgo.v11.i1.48] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v11/i1/48.htm |
| Number | Citing Articles |
| 1 |
Zsolt Varga, Adrienn Bíró, Miklós Török, Dezső Tóth. A combined approach for individualized lymphadenectomy in gastric cancer patients. Pathology and Oncology Research 2023; 29 doi: 10.3389/pore.2023.1611270
|
| 2 |
Xin Zhang, Hejing Huang, Ziran Wei, Zhenxin Zhu, Dejun Yang, Hongbing Fu, Jiapeng Xu, Zunqi Hu, Yu Zhang, Qing You, Xin Huang, Ronglin Yan, Weimin Wang, Qingping Cai. <p>Comparison of Docetaxel + Oxaliplatin + S-1 vs Oxalipatin + S-1 as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Propensity Score Matched Analysis</p>. Cancer Management and Research 2020; : 6641 doi: 10.2147/CMAR.S258360
|
| 3 |
Avani Athauda, Matthew Nankivell, Rupert Langer, Susan Pritchard, Ruth E. Langley, Katharina von Loga, Naureen Starling, Ian Chau, David Cunningham, Heike I. Grabsch. Pathological regression of primary tumour and metastatic lymph nodes following chemotherapy in resectable OG cancer: pooled analysis of two trials. British Journal of Cancer 2023; 128(11): 2036 doi: 10.1038/s41416-023-02217-x
|
| 4 |
Sonay K Ozturk, Cristina G Martinez, David Mens, Cornelis Verhoef, Miriam Tosetto, Kieran Sheahan, Johannes H W de Wilt, Geke A P Hospers, Cornelis J H van de Velde, Corrie A M Marijnen, Rachel S van der Post, Iris D Nagtegaal. Lymph node regression after neoadjuvant chemoradiotherapy in rectal cancer. Histopathology 2024; 84(6): 935 doi: 10.1111/his.15134
|
| 5 |
Andrianos Tsekrekos, Michael Vieth, Nelson Ndegwa, Adrian Bateman, Jean-François Flejou, Heike I. Grabsch, Luca Mastracci, Sybren L. Meijer, Luca Saragoni, Kieran Sheahan, Jayant Shetye, Rhonda Yantiss, Lars Lundell, Sönke Detlefsen. Interobserver agreement of a gastric adenocarcinoma tumor regression grading system that incorporates assessment of lymph nodes. Human Pathology 2021; 116: 94 doi: 10.1016/j.humpath.2021.07.003
|
| 6 |
Marina Alessandra Pereira, Marcus Fernando Kodama Pertille Ramos, Andre Roncon Dias, Leonardo Cardili, Renan Ribeiro e Ribeiro, Amir Zeide Charruf, Tiago Biachi de Castria, Bruno Zilberstein, Ivan Ceconello, Venancio Avancini Ferreira Alves, Ulysses Ribeiro, Evandro Sobroza de Mello. Lymph node regression after neoadjuvant chemotherapy: A predictor of survival in gastric cancer. Journal of Surgical Oncology 2020; 121(5): 795 doi: 10.1002/jso.25785
|
| 7 |
Pengfei Su, Yingjing Zhang, Tian Yu, Lin Jiang, Weiming Kang, Yuqin Liu, Jianchun Yu. Comparison of the predictive value of pathological response at primary tumor and lymph node status after neoadjuvant chemotherapy in locally advanced gastric cancer. Clinical and Translational Oncology 2023; 25(8): 2462 doi: 10.1007/s12094-023-03130-8
|
| 8 |
Zhenyu Wang, Tingting You, Chengyuan Cai, Qianyi Su, Jinmei Cheng, Jisheng Xiao, Xiaopin Duan. Biomimetic Gold Nanostructure with a Virus-like Topological Surface for Enhanced Antigen Cross-Presentation and Antitumor Immune Response. ACS Applied Materials & Interfaces 2023; doi: 10.1021/acsami.2c21028
|
| 9 |
Daniel Reim, Alexander Novotny, Helmut Friess, Julia Slotta‐Huspenina, Wilko Weichert, Katja Ott, Bastian Dislich, Sylvie Lorenzen, Karen Becker, Rupert Langer. Significance of tumour regression in lymph node metastases of gastric and gastro‐oesophageal junction adenocarcinomas. The Journal of Pathology: Clinical Research 2020; 6(4): 263 doi: 10.1002/cjp2.169
|
| 10 |
Marek Osecky, Dino Kröll, Marcus Feith, Daniel Reim, Bastian Dislich, Karen Becker, Rupert Langer. Tumor Regression in Lymph Node Metastases of Esophageal Adenocarcinomas after Neoadjuvant Therapy. Gastrointestinal Disorders 2020; 2(4): 397 doi: 10.3390/gidisord2040036
|
| 11 |
Paulo Matos da Costa, Patrícia Lages, Susana Onofre, Ruy M. Ribeiro. The impact of negative lymph nodes in the survival outcomes of pN+ patients following radical gastrectomy: the inverse lymph node ratio as a better score to study negative lymph nodes. Updates in Surgery 2020; 72(4): 1031 doi: 10.1007/s13304-020-00757-y
|
| 12 |
Visvakanth Sivanathan, Christoph Utz, Thomas Thomaidis, Friedrich Förster, Michael Stahl, Florian Lordick, Stefan Ibach, Stephan Kanzler, Andreas Adler, Stefan Paul Mönig, Carl C. Schimanski, Andre Ignee, Christoph F. Dietrich, Peter R. Galle, Markus Moehler. Predictive Value of Preoperative Endoscopic Ultrasound (EUS) After Neoadjuvant Chemotherapy in Locally Advanced Esophagogastric Cancer – Data From a Randomized German Phase II Trial. Ultraschall in der Medizin - European Journal of Ultrasound 2022; 43(05): 514 doi: 10.1055/a-1593-4401
|
| 13 |
Liucheng Wu, Zhaoqiong Xing, Mingwei Huang, Hongping Yu, Yuzhou Qin, Qinwen Jin, Zihan Zhou, Jiansi Chen. Nodal downstaging to ypN0 after neoadjuvant chemotherapy positively impacts on survival of cT4N+ GC/GEJ patients. Journal of Surgical Oncology 2022; 126(8): 1403 doi: 10.1002/jso.27065
|
| 14 |
Bing Liu, Yu-Jie Xu, Feng-Ran Chu, Guang Sun, Guo-Dong Zhao, Sheng-Zhong Wang. Development of a clinical nomogram for prediction of response to neoadjuvant chemotherapy in patients with advanced gastric cancer. World Journal of Gastrointestinal Surgery 2024; 16(2): 396-408 doi: 10.4240/wjgs.v16.i2.396
Abstract(105) |
Core Tip(84) |
Full Article(HTML)(469)
|
Full Article with Cover (PDF)-1256K(26)
|
Full Article (Word)-536K(5)
|
Audio-2572K(0)
|
Peer-Review Report-227K(10)
|
Answering Reviewers-76K(11)
|
Full Article (PDF)-999K(25)
|
Full Article (XML)-145K(13)
|
Times Cited (0)
|
Total Visits (1467)
|
Open
|
| 15 |
Zuzanna Pelc, Magdalena Skórzewska, Karol Rawicz-Pruszyński, Wojciech P. Polkowski. Lymph Node Involvement in Advanced Gastric Cancer in the Era of Multimodal Treatment—Oncological and Surgical Perspective. Cancers 2021; 13(10): 2509 doi: 10.3390/cancers13102509
|
| 16 |
Maria Cecília de Aguiar MACHADO, José Pedro Coimbra de Vargas Lobarinhas BARBOSA, Filipa Ferreira de OLIVEIRA, José Adelino Lobarinhas BARBOSA. MORBIDITY AND SURVIVAL AFTER PERIOPERATIVE CHEMOTHERAPY IN GASTRIC CANCER: A STUDY USING THE BECKER’S CLASSIFICATION AND REGRESSION. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2022; 35 doi: 10.1590/0102-672020220002e1704
|
| 17 |
Xian-Wen Liang, Wei-Sheng Xiao, Hao Lei, Qian-Cheng Huag, Yu-Lan Dong, Fang Wang, Wei-Peng Qing. Risk model and factors for prediction of response to neoadjuvant chemotherapy in patients with advanced gastric cancer-a two-center cohort study. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10513-1
|